ING Groep NV Trims Stake in Healthpeak Properties, Inc. (NYSE:DOC)

ING Groep NV reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 7.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 89,338 shares of the real estate investment trust’s stock after selling 6,990 shares during the quarter. ING Groep NV’s holdings in Healthpeak Properties were worth $1,811,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of DOC. State Street Corp purchased a new position in Healthpeak Properties during the third quarter valued at approximately $1,093,576,000. Geode Capital Management LLC purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at $403,898,000. Principal Financial Group Inc. boosted its holdings in Healthpeak Properties by 2,113.5% in the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares during the period. Charles Schwab Investment Management Inc. bought a new position in Healthpeak Properties in the 3rd quarter worth $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Healthpeak Properties in the 3rd quarter worth $175,697,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DOC. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Wells Fargo & Company lowered their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Mizuho cut their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Robert W. Baird reduced their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 11th. Finally, Wedbush dropped their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Moderate Buy” and an average target price of $24.00.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $19.75 on Monday. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The firm has a fifty day simple moving average of $20.20 and a two-hundred day simple moving average of $21.39. Healthpeak Properties, Inc. has a 52 week low of $16.01 and a 52 week high of $23.26. The stock has a market capitalization of $13.81 billion, a P/E ratio of 56.42, a PEG ratio of 2.17 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be given a $0.305 dividend. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 6.18%. The ex-dividend date of this dividend is Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.